InvestSMART

PharmX Technologies Limited (ASX: PHX) - Announcements

- Current share price for PHX : $0.100

ASX company news and announcements for PharmX Technologies Limited (PHX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmX Technologies Limited (PHX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmX Technologies Limited (PHX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmX Technologies Limited (PHX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$67 H1 FY25 Results Announcement 19 Feb 2025 8:46AM $0.083 $0.100 risen by 20.48%
$67 Half Yearly Report and Accounts 19 Feb 2025 8:45AM $0.083 $0.100 risen by 20.48%
$67 Pharmx announces strategic partnership with Toniq 18 Feb 2025 10:47AM $0.083 $0.100 risen by 20.48%
$67 Notice of Results Announcement 3 Feb 2025 1:25PM $0.077 $0.100 risen by 29.87%
$67 Change of Company Secretary 28 Nov 2024 9:08AM $0.069 $0.100 risen by 44.93%
$67 Results of Annual General Meeting 26 Nov 2024 1:42PM $0.075 $0.100 risen by 33.33%
$67 Chairman's Address & AGM Presentation 26 Nov 2024 9:28AM $0.071 $0.100 risen by 40.85%
$67 Notification of cessation of securities - PHX 21 Nov 2024 8:22AM $0.057 $0.100 risen by 75.44%
$67 Investor Presentation 30 Oct 2024 1:53PM $0.043 $0.100 risen by 132.56%
$67 Notice of Annual General Meeting/Proxy Form 25 Oct 2024 9:06AM $0.042 $0.100 risen by 138.10%
$67 Initial Director's Interest Notice 9 Sep 2024 9:55AM $0.050 $0.100 risen by 100%
$67 Alternate Director 9 Sep 2024 9:07AM $0.050 $0.100 risen by 100%
$67 Corporate Governance Statement and Appendix 4G 3 Sep 2024 3:00PM $0.041 $0.100 risen by 143.90%
$67 Investor Presentation 27 Aug 2024 10:07AM $0.040 $0.100 risen by 150%
$67 FY24 Results 27 Aug 2024 8:34AM $0.040 $0.100 risen by 150%
$67 2024 Annual Report and Appendix 4E 27 Aug 2024 8:33AM $0.040 $0.100 risen by 150%
$67 Delay of Results Announcement 16 Aug 2024 2:50PM $0.040 $0.100 risen by 150%
$67 Letter to Shareholders 9 Aug 2024 9:22AM $0.045 $0.100 risen by 122.22%
$67 Update on Fred Appeals in Legal Proceedings 9 Aug 2024 9:21AM $0.045 $0.100 risen by 122.22%
$67 Trading Halt 8 Aug 2024 9:52AM $0.045 $0.100 risen by 122.22%
$67 Update Fred Appeal legal proceedings re Corum Systems/PharmX 6 Aug 2024 2:39PM $0.045 $0.100 risen by 122.22%
$67 Ceasing to be a substantial shareholder from AEF 31 Jul 2024 3:54PM $0.046 $0.100 risen by 117.39%
$67 Change in substantial shareholding from AEF 30 Jul 2024 4:34PM $0.052 $0.100 risen by 92.31%
$67 Notice of Results Announcement 30 June 2024 24 Jul 2024 8:15AM $0.050 $0.100 risen by 100%
$67 ATO confirms tax implications of return of share capital 18 Jul 2024 8:50AM $0.050 $0.100 risen by 100%

51 - 75 of 93 results

Page 3 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.